The Future of Predictive Safety Evaluation: In Two Volumes Volumes 2
Editat de A.N. Worden, D.V. Parke, J. Marksen Limba Engleză Paperback – 28 dec 2011
Preț: 356.31 lei
Preț vechi: 375.06 lei
-5% Nou
Puncte Express: 534
Preț estimativ în valută:
68.19€ • 72.11$ • 56.88£
68.19€ • 72.11$ • 56.88£
Carte tipărită la comandă
Livrare economică 28 decembrie 24 - 11 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789401079365
ISBN-10: 9401079366
Pagini: 324
Ilustrații: 320 p.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.45 kg
Ediția:Softcover reprint of the original 1st ed. 1987
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9401079366
Pagini: 324
Ilustrații: 320 p.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.45 kg
Ediția:Softcover reprint of the original 1st ed. 1987
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
1 Molecular Aspects of Toxicology.- 1 Molecular aspects of toxicology.- 2 Preclinical: In Vivo and Combined Approaches.- 2 The organization of preclinical and premarketing toxicity.- 3 Animal models of responses resulting from short-term exposures.- 4 Animal models of long term toxic effects.- 5 Inhalation aspects of toxicology testing.- 6 Testing for reproductive toxicity.- 7 Neurotoxicity.- 8 Safety evaluation — carcinogenic risks.- 3 Nutrition and Toxicological Prediction.- 9 Diet and the future of drug safety evaluation.- 9.1 Introduction — Laboratory Diets.- 9.2 Interaction of Drugs and Nutrients.- 9.3 Immune Function and Diet.- 9.4 Cancer and Diet.- 9.5 Influence of Diet on Longevity.- 9.6 Essential Fatty Acids, Prostaglandins And Anti-Inflammatory Drugs.- 9.7 Influence of Diet on Various Disorders.- 9.8 General Conclusions — Dietary Considerations Relative To Future Toxicology.- 4 Applied Aspects.- 10 Toxicology for pharmaceutical substances: the needs.- 11 Predictive safety evaluation: the clinical trial.- 12 Artificial sweeteners and the control of appetite: implications for the eating disorders.- 13 Tobacco and smoking products.- 14 New challenges in the safety evaluation of drugs and biologies.